Join
Live feed
·
INSIDERFilingvia Quantisnow
Dicerna Pharmaceuticals, Inc. logo

SEC Form 4: Fambrough Douglas exercised 179,865 shares at a strike of $3.34, increasing direct ownership by 417% to 223,029 units

ByQuantisnow·Wall Street's wire, on your screen.
DRNA· Dicerna Pharmaceuticals, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRNA (Dicerna Pharmaceuticals, Inc.) and more on Quantisnow.